eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease

Fever Without a Focus

Author: Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Contributor Information and Disclosures

Updated: Jan 22, 2009

Introduction

Background

Infants or young children who have a fever with no obvious source of infection present a diagnostic dilemma. Health care providers see these patients on a daily basis. As many as 20% of childhood fevers have no apparent cause.1 A small but significant number of these patients may have a serious bacterial infection; the risk is greatest among febrile infants and children younger than 36 months, making proper diagnosis and management important. Physical examination and patient history do not always identify patients with occult bacteremia or serious bacterial infection. Serious infections that are not recognized promptly and treated appropriately can cause significant morbidity or mortality.

This article focuses primarily on infants and young children aged 2-36 months and reflects the significant changes in the care of the febrile infant and child over the past 10 years. The article Fever in the Young Infant addresses the diagnosis and treatment of febrile infants younger than 2 months.

Fever is defined as a rectal temperature that exceeds 38°C (100.4°F). Direct the initial evaluation of these patients toward identifying occult bacteremia or other serious bacterial infections. Address the following questions:

  • What laboratory studies are indicated for various age ranges?
  • Which patients need in-depth evaluation and treatment?
  • Which patients need treatment with antibiotics?
  • Which patients should be hospitalized?
  • Which patients can be sent home safely and what follow-up is appropriate for them?
  • Are the diagnosis and treatment modalities for each patient cost-effective?
  • What is the potential morbidity associated with testing and treatment?
  • What are the parental (and patient) preferences for testing and treatment?

A great deal of time and effort has been spent on research to help identify the febrile infant and young child with a serious bacterial infection. However, evaluation and treatment of febrile infants and young children vary, despite nationally published treatment guidelines.

Pathophysiology

Meningitis, pneumonia, urinary tract infection (UTI), and bacteremia are serious etiologies of fever in infants and young children.

Neonates' immature immune systems place them at greater risk of systemic infection. Hematogenous spread of infection is most common in this age group or in patients who are immunocompromised. For these same reasons, infants who have a focal bacterial infection have a greater risk of developing metastatic infection or bacteremia.

The following are among the most common bacterial etiologies of serious bacterial infection in this age group:

  • Streptococcus pneumoniae
  • Streptococcus agalactiae
  • Neisseria meningitidis
  • Haemophilus influenzae type b
  • Listeria monocytogenes
  • Escherichia coli

Historically, approximately 2.5-3% of highly febrile children younger than 3 years have occult bacteremia, which typically is caused by S pneumoniae. The advent of conjugate pneumococcal vaccine has resulted in a decrease in pneumococcal occult bacteremia and other disease.2 Viral infections are common in the young child as well; however, exclude serious bacterial infection prior to assuming a viral etiology for the fever.

Frequency

United States

Fever accounts for 10-20% of pediatric visits to health care providers.

Mortality/Morbidity

Patients with no easily identified source of infection have a small but significant risk of a serious bacterial infection. If not recognized and treated appropriately and promptly, this can cause morbidity or mortality.

Age

This article focuses on the diagnosis and treatment of febrile children aged 2-36 months.

Clinical

History

Obtaining an accurate history from the parent or caregiver is important when assessing fever without a focus; the history obtained should include the following information:

  • Fever history: What was child's temperature prior to presentation and how was temperature measured? Consider fever documented at home by a reliable parent or caregiver the same as fever found upon presentation. Accept parental reports of maximum temperature.
  • Fever at presentation
    • If the physician believes the infant has been excessively bundled, and if a repeat temperature taken 15-30 minutes after unbundling is normal, the infant should be considered afebrile.
    • Always remember that normal or low temperature does not preclude serious, even life-threatening, infectious disease.
  • Current level of activity or lethargy
  • Activity level prior to fever onset (ie, active, lethargic)
  • Current eating and drinking pattern
  • Eating and drinking pattern prior to fever onset
  • Appearance: Fever sometimes makes a child appear rather ill.
  • Vomiting or diarrhea
  • Ill contacts
  • Medical history
  • Immunization history (especially recent immunizations)
  • Urinary output: Inquire as to the number of wet diapers.

Physical

While performing a complete physical examination, pay particular attention to assessing hydration status and identifying the source of infection. Physical examination of every febrile child should include the following:

  • Record vital signs.
    • Temperature: Rectal temperature is the standard. Temperature obtained via tympanic, axillary, or oral methods may not truly reflect the patient's temperature.
    • Pulse rate
    • Respiratory rate
    • Blood pressure
  • Measure pulse oximetry levels.
    • Pulse oximetry may be a more sensitive predictor of pulmonary infection than respiratory rate in patients of all ages, but especially in infants and young children.
    • Pulse oximetry is mandatory for any child with abnormal lung examination findings, respiratory symptoms, or abnormal respiratory rate, although keep in mind that the respiratory rate increases when children are febrile.
  • Record an accurate weight on every chart.
    • All pharmacologic and procedural treatments are based on the weight in kilograms.
    • In urgent situations, estimating methods (eg, Broselow tape, weight based on age) may be used.
  • During the examination, concentrate on identifying any of the following:
    • Toxic appearance, which suggests possible signs of lethargy, poor perfusion, hypoventilation or hyperventilation, or cyanosis (ie, shock)
    • A focus of infection that is the apparent cause of the fever
    • Minor foci (eg, otitis media [OM], pharyngitis, sinusitis, skin or soft tissue infection)
    • Identifiable viral infection (eg, bronchiolitis, croup, gingivostomatitis, viral gastroenteritis, varicella, hand-foot-and-mouth disease)
    • Petechial or purpuric rashes, often associated with bacteremia
    • Purpura, which is associated more often with meningococcemia than is the presence of petechiae alone
  • For all patients aged 3-36 months, management decisions are mostly based on the degree of toxicity and the height of temperature.
  • The Yale Observation Scale is a reliable method for determining degree of illness.3,4
    • It consists of 6 variables: quality of cry, reaction to parent stimulation, state variation, color, hydration, and response. A score of 10 or less has a 2.7% risk of serious bacterial infection. A score of 16 or greater has a 92% risk of serious bacterial infection.
    • Regarding the height of temperature, Hoberman et al found that 6.5% of patients with a temperature of 39.0°C (102.2°F) or more had a UTI and that white females with that temperature had a 17% incidence of UTI.5 In this age group, the prevalence of bacteremia correlates with the height of fever.
    • Children with temperatures from 39-39.5°C (102.2-103°F) have an approximate 2-4% risk of having occult bacteremia. Those with temperatures higher than 39.5°C (103°F) have an approximate 5% chance of having occult bacteremia.
    • The impact of the conjugated pneumococcal vaccine on these findings and predictions has not been evaluated.
    • Summary of the Yale Observation Scale

      Open table in new window

      Table
      Observation Items1 (Normal)3 (Moderate Impairment)5 (Severe Impairment)
      Quality of cryStrong with normal tone or contentment without cryingWhimpering or sobbingWeak cry, moaning, or high-pitched cry
      Reaction to parent stimulationBrief crying that stops or contentment without cryingIntermittent cryingContinual crying or limited response
      ColorPinkAcrocyanotic or pale extremitiesPale or cyanotic or mottled or ashen
      State variationIf awake, stays awake; if asleep, wakes up quickly upon stimulationEyes closed briefly while awake or awake with prolonged stimulationFalls asleep or will not arouse
      HydrationSkin normal, eyes normal, and mucous membranes moistSkin and eyes normal and mouth slightly drySkin doughy or tented, dry mucous membranes, and/or sunken eyes
      Response (eg, talk, smile) to social overturesSmiling or alert (<2 mo)Briefly smiling or alert briefly (<2 mo)Unsmiling anxious face or dull, expressionless, or not alert (<2 mo)
      Observation Items1 (Normal)3 (Moderate Impairment)5 (Severe Impairment)
      Quality of cryStrong with normal tone or contentment without cryingWhimpering or sobbingWeak cry, moaning, or high-pitched cry
      Reaction to parent stimulationBrief crying that stops or contentment without cryingIntermittent cryingContinual crying or limited response
      ColorPinkAcrocyanotic or pale extremitiesPale or cyanotic or mottled or ashen
      State variationIf awake, stays awake; if asleep, wakes up quickly upon stimulationEyes closed briefly while awake or awake with prolonged stimulationFalls asleep or will not arouse
      HydrationSkin normal, eyes normal, and mucous membranes moistSkin and eyes normal and mouth slightly drySkin doughy or tented, dry mucous membranes, and/or sunken eyes
      Response (eg, talk, smile) to social overturesSmiling or alert (<2 mo)Briefly smiling or alert briefly (<2 mo)Unsmiling anxious face or dull, expressionless, or not alert (<2 mo)

Causes

Several common bacteria cause serious bacterial infections, including the following:

  • S pneumoniae
    • S pneumoniae is the leading cause of nearly all common bacterial upper respiratory tract infections (eg, pneumonia, sinusitis, OM).
    • This organism is the most common cause of meningitis in the United States, although the use of the pneumococcal vaccine will likely change this.
    • It is the most common cause of occult bacteremia, the incidence of which is decreasing.
  • N meningitidis
  • H influenzae type b
  • L monocytogenes
  • E coli
    • E coli is the most common cause of UTIs.
    • Among febrile children with UTIs, 75% have pyelonephritis, with consequences that, if missed, include renal scarring in 27-64% of patients, a 23% risk of hypertension, a 10% risk of renal failure, and a 13% risk of preeclampsia as adults.
    • Approximately 13-15% of end-stage renal disease is believed to be related to undertreated childhood UTIs.

More on Fever Without a Focus

Overview: Fever Without a Focus
Differential Diagnoses & Workup: Fever Without a Focus
Treatment & Medication: Fever Without a Focus
Follow-up: Fever Without a Focus
References

References

  1. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med. Dec 2000;36(6):602-14. [Medline].

  2. Benito-Fernandez J, Raso SM, Pocheville-Gurutzeta I, SanchezEtxaniz J, Azcunaga-Santibanez B, Capape-Zache S. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Pediatr Infect Dis J. Aug 2007;26(8):667-71. [Medline].

  3. McCarthy PL, Sharpe MR, Spiesel SZ. Observation scales to identify serious illness in febrile children. Pediatrics. Nov 1982;70(5):802-9. [Medline].

  4. Bonadio WA. The history and physical assessments of the febrile infant. Pediatr Clin North Am. Feb 1998;45(1):65-77. [Medline].

  5. Hoberman A, Wald ER, Reynolds EA. Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever. J Pediatr. Apr 1994;124(4):513-9. [Medline].

  6. Murphy CG, van de Pol AC, Harper MB, Bachur RG. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med. Mar 2007;14(3):243-9. [Medline].

  7. ACEP. Clinical policy for children younger than three years presenting to the emergency department with fever. ACEP Clinical Policies Committee; ACEP Clinical Policies Subcommittee on Pediatric Fever. Ann Emerg Med. Oct 2003;42(4):530-45. [Medline].

  8. Akintemi OB, Roberts KB. Evaluation and management of the febrile child in the conjugated vaccine era. Adv Pediatr. 2006;53:255-78. [Medline].

  9. Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. Aug 2007;26(8):672-7. [Medline].

  10. Antonyrajah B, Mukundan D. Fever without apparent source on clinical examination. Curr Opin Pediatr. Feb 2008;20(1):96-102. [Medline].

  11. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med. Nov 11 1993;329(20):1437-41. [Medline].

  12. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. Jul 1993;22(7):1198-210. [Medline].

  13. Bergman DA, Mayer ML, Pantell RH, Finch SA, Wasserman RC. Does clinical presentation explain practice variability in the treatment of febrile infants?. Pediatrics. Mar 2006;117(3):787-95. [Medline].

  14. Bonadio WA, Hagen E, Rucka J, et al. Efficacy of a protocol to distinguish risk of serious bacterial infection in the outpatient evaluation of febrile young infants. Clin Pediatr (Phila). Jul 1993;32(7):401-4. [Medline].

  15. Bonadio WA, Lehrmann M, Hennes H, et al. Relationship of temperature pattern and serious bacterial infections in infants 4 to 8 weeks old 24 to 48 hours after antibiotic treatment. Ann Emerg Med. Sep 1991;20(9):1006-8. [Medline].

  16. Chinnock R, Butto J, Fernando N. Hot tots: current approach to the young febrile infant. Compr Ther. 1995;21(3):109-14. [Medline].

  17. Grubb NS, Lyle S, Brodie JH, et al. Management of infants and children 0 to 36 months of age with fever without source. J Am Board Fam Pract. Mar-Apr 1995;8(2):114-9. [Medline].

  18. Herd D. In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus?. Arch Dis Child. Apr 2007;92(4):362-4. [Medline].

  19. Ishimine P. Fever without source in children 0 to 36 months of age. Pediatr Clin North Am. Apr 2006;53(2):167-94. [Medline].

  20. Ishimine P. The evolving approach to the young child who has fever and no obvious source. Emerg Med Clin North Am. Nov 2007;25(4):1087-115, vii. [Medline].

  21. Jaskiewicz JA, McCarthy CA. Evaluation and management of the febrile infant 60 days of age or younger. Pediatr Ann. Aug 1993;22(8):477-80, 482-3. [Medline].

  22. Jaskiewicz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics. Sep 1994;94(3):390-6. [Medline].

  23. Kramer MS, Tange SM, Drummond KN. Urine testing in young febrile children: a risk-benefit analysis. J Pediatr. Jul 1994;125(1):6-13. [Medline].

  24. Lacour AG, Zamora SA, Gervaix A. A score identifying serious bacterial infections in children with fever without source. Pediatr Infect Dis J. Jul 2008;27(7):654-6. [Medline].

  25. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med. Jul 1998;152(7):624-8. [Medline].

  26. Lieu TA, Baskin MN, Schwartz JS, Fleisher GR. Clinical and cost-effectiveness of outpatient strategies for management of febrile infants. Pediatrics. Jun 1992;89(6 Pt 2):1135-44. [Medline].

  27. Maheshwari N. How useful is C-reactive protein in detecting occult bacterial infection in young children with fever without apparent focus?. Arch Dis Child. Jun 2006;91(6):533-5. [Medline].

  28. Massin MM, Montesanti J, Lepage P. Management of fever without source in young children presenting to an emergency room. Acta Paediatr. Nov 2006;95(11):1446-50. [Medline].

  29. McCarthy PL, Lembo RM, Baron MA. Predictive value of abnormal physical examination findings in ill-appearing and well-appearing febrile children. Pediatrics. Aug 1985;76(2):167-71. [Medline].

  30. McCarthy PL, Lembo RM, Fink HD. Observation, history, and physical examination in diagnosis of serious illnesses in febrile children less than or equal to 24 months. J Pediatr. Jan 1987;110(1):26-30. [Medline].

  31. Myers C, Gervaix A. Streptococcus pneumoniae bacteraemia in children. Int J Antimicrob Agents. Nov 2007;30 Suppl 1:S24-8. [Medline].

  32. Nozicka CA. Evaluation of the febrile infant younger than 3 months of age with no source of infection. Am J Emerg Med. Mar 1995;13(2):215-8. [Medline].

  33. Oppenheim PI, Sotiropoulos G, Baraff LJ. Incorporating patient preferences into practice guidelines: management of children with fever without source. Ann Emerg Med. Nov 1994;24(5):836-41. [Medline].

  34. Pena BM, Harper MB, Fleisher GR. Occult bacteremia with group B streptococci in an outpatient setting. Pediatrics. Jul 1998;102(1 Pt 1):67-72. [Medline].

  35. Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis. Arch Pediatr Adolesc Med. Jun 2004;158(6):521-6. [Medline].

  36. Richardson M, Lakhanpaul M. Assessment and initial management of feverish illness in children younger than 5 years: summary of NICE guidance. BMJ. Jun 2 2007;334(7604):1163-4. [Medline].

  37. Rothrock SG, Harper MB, Green SM, et al. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta- analysis. Pediatrics. Mar 1997;99(3):438-44. [Medline].

  38. Roukema J, Steyerberg EW, van der Lei J, Moll HA. Randomized trial of a clinical decision support system: impact on the management of children with fever without apparent source. J Am Med Inform Assoc. Jan-Feb 2008;15(1):107-13. [Medline].

  39. Seow VK, Lin AC, Lin IY, Chen CC, Chen KC, Wang TL, et al. Comparing different patterns for managing febrile children in the ED between emergency and pediatric physicians: impact on patient outcome. Am J Emerg Med. Nov 2007;25(9):1004-8. [Medline].

  40. [Best Evidence] Shaikh N, Morone NE, Lopez J, et al. Does this child have a urinary tract infection?. JAMA. Dec 26 2007;298(24):2895-904. [Medline].

  41. Vega R. Rapid viral testing in the evaluation of the febrile infant and child. Curr Opin Pediatr. Jun 2005;17(3):363-7. [Medline].

  42. Wasserman GM, White CB. Evaluation of the necessity for hospitalization of the febrile infant less than three months of age. Pediatr Infect Dis J. Mar 1990;9(3):163-9. [Medline].

Further Reading

Keywords

fever without a focus, bronchiolitis, childhood fever, croup, cyanosis, end-stage renal disease, Escherichia coli, fever without a source, fever without localizing signs, gingivostomatitis, Haemophilus influenzae type b, hand-foot-and-mouth disease, hyperventilation, hypoventilation, Listeria monocytogenes, meningitis, Neisseria meningitidis, occult bacteremia, otitis media, pediatric fever, pharyngitis, pneumonia, pyelonephritis, renal failure, renal scarring, sinusitis, Streptococcus agalactiae, Streptococcus pneumoniae, urinary tract infection, UTI, varicella, viral gastroenteritis

Contributor Information and Disclosures

Author

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Consulting; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching; sanofi pasteur Grant/research funds Unrestricted research grant; sanofi pasteur  Consulting; sanofi pasteur Honoraria Speaking and teaching; Tap Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching

Medical Editor

Ashir Kumar, MBBS, MD, FAAP, Professor, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University; Consulting Staff, Department of Pediatrics, EW Sparrow Hospital
Ashir Kumar, MBBS, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American Association of Physicians of Indian Origin, American Federation for Clinical Research, American Society for Microbiology, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Mark R Schleiss, MD, American Legion Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota School of Medicine
Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting; Pfizer Honoraria Consulting

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.